Institute of Medicine, University of Bergen
Bergen, 5021, Norway
NCT Number: NCT01641055
The purpose of this study is to compare the possible health benefits of intake of proteins from salmon, herring, cod and milk on glucose tolerance in overweight and obese adults. Overweight and obese subjects often have reduced glucose tolerance, and previous findings from a study on cod proteins suggested that glucose tolerance was improved.
Looking for future studies?
Notify Me18 year–69 year
All sexes
Interventional
Not applicable
Bergen, 5021, Norway
Participants receive 2.5g protein per day for 8 weeks as tablets.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2.5g salmon protein hydrolysate per day for 8wk.
2.5g herring protein hydrolysate per day for 8wk.
2.5g cod protein per day for 8wk.
2.5g milk protein per day for 8wk.
Time frame: 8 weeks
Glucose will be measured in fasting and postprandial samples
Time frame: 8 weeks
Time frame: 8 weeks
Time frame: 8 weeks
Time frame: 8 weeks
Concentrations of relevant metabolites and co-factors were measured in serum and urine
University of Bergen
Other
A 8 wk Study to Compare the Effects of Proteins Various Fish Species (Salmon, Herring, Cod) and Milk on Glucose Regulation in Overweight and Obese Adults.
Acronym: FISK3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsNCT00342732
Body Weight, Nutrition Disorders
Phoenix, Arizona, United States
View Trial DetailsNCT00445627
Body Weight, Diabetes Mellitus
Bethesda, Maryland, United States
View Trial DetailsNCT06904105
Body Weight, Nutrition Disorders
Beijing, Beijing Municipality, China
View Trial Details